Confirmed Venomous Crustacean

Researchers show that a cave-dwelling crustacean may use venom to immobilize and digest its prey.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Live remipedePLOS ONE, J. VAN DER HAMMany species of scorpions, spiders, and centipedes produce venom, which they use to catch prey or defend themselves. Although they, too, are athropods, until now, no one had definitively found a species of venomous crustacean. But researchers from the Natural History Museum in London have shown evidence of such a critter, and showed in a Molecular Biology and Evolution paper published last week (October 16) that the aquatic, cave-dwelling crustacean (Speleonectes tulumensis) expresses known venom genes and produces a neurotoxin.

S. tulumensis is a member of a group called the remipedes, which were described for the first time in 1981. The crustaceous creatures look a bit like centipedes, but live underwater in caves, and are blind. The Natural History team discovered the crustacean’s unprecedented toxin-producing ability using transcriptomics. The researchers found that most of the venom genes that S. tulumensis expressed were digestive enzymes, like chitinases and peptidases. They also showed that S. tulumensis expressed a neurotoxin that is similar to one found in some spiders. “We think the neurotoxin is stopping their prey getting away and that the peptidases are allowing the remipedes to drink their prey like milkshakes,” senior author Ronald Jenner, a biologist at the Natural History Museum, told Nature.

“There might ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies